Moreover, to explore the effects of the METTL3-IGF2BP3 axis on the metastatic and invasive ability of pancreatic cancer cells, we performed a number of series of in vivo and in vitro experiments. This evidence concerns the gene IGF2BP3 and familial pancreatic carcinoma.